A citation-based method for searching scientific literature

Archana Upadhya, Khushwant S Yadav, Ambikanandan Misra. Expert Opin Drug Deliv 2021
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
50

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.
Zhi-Jie Xiao, Jing Liu, Si-Qi Wang, Yun Zhu, Xu-Yuan Gao, Vicky Pui-Chi Tin, Jing Qin, Jun-Wen Wang, Maria Pik Wong. Elife 2017
30
25

Estrogen-induced FOS-like 1 regulates matrix metalloproteinase expression and the motility of human endometrial and decidual stromal cells.
Chao Chen, Congcong Li, Weichun Liu, Feng Guo, Xi Kou, Si Sun, Taiyang Ye, Shanji Li, Aimin Zhao. J Biol Chem 2020
13
25

Surfactin-induced apoptosis through ROS-ERS-Ca2+-ERK pathways in HepG2 cells.
Chun-ling Wang, Chuan Liu, Li-li Niu, Li-rui Wang, Li-hua Hou, Xiao-hong Cao. Cell Biochem Biophys 2013
39
25

New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trials.
Danilo Rocco, Vanesa Gregorc, Luigi Della Gravara, Chiara Lazzari, Giovanni Palazzolo, Cesare Gridelli. Expert Opin Investig Drugs 2020
8
25

Photodynamic action of palmatine hydrochloride on colon adenocarcinoma HT-29 cells.
Juan Wu, Qicai Xiao, Na Zhang, Changhu Xue, Albert Wingnang Leung, Hongwei Zhang, Chuanshan Xu, Qing-Juan Tang. Photodiagnosis Photodyn Ther 2016
15
25


Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1.
Divya Chakravarthy, Amanda R Muñoz, Angel Su, Rosa F Hwang, Brian R Keppler, Daniel E Chan, Glenn Halff, Rita Ghosh, Addanki P Kumar. Cancer Lett 2018
31
25


Interaction of estrogen receptor β5 and interleukin 6 receptor in the progression of non-small cell lung cancer.
Hexiao Tang, Yuquan Bai, Lecai Xiong, Li Zhang, Yanhong Wei, Minglin Zhu, Xiaoling Wu, Ding Long, Junhui Yang, Li Yu,[...]. J Cell Biochem 2018
6
25


The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
Emily Golden, Rabab Rashwan, Eleanor A Woodward, Agustin Sgro, Edina Wang, Anabel Sorolla, Charlene Waryah, Wan Jun Tie, Elisabet Cuyàs, Magdalena Ratajska,[...]. Nat Commun 2021
5
25


Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.
Gaylor Boulay, Nicolas Malaquin, Ingrid Loison, Bénédicte Foveau, Capucine Van Rechem, Brian R Rood, Albin Pourtier, Dominique Leprince. J Biol Chem 2012
25
25


Network Pharmacology: Exploring the Resources and Methodologies.
Junaid Muhammad, Abbas Khan, Arif Ali, Li Fang, Wang Yanjing, Qin Xu, Dong-Qing Wei. Curr Top Med Chem 2018
26
25

Protopine isolated from Nandina domestica induces apoptosis and autophagy in colon cancer cells by stabilizing p53.
Younglim Son, Younju An, Jaeyeon Jung, Sora Shin, InWha Park, Jungsug Gwak, Bong Gun Ju, Young-Hwa Chung, MinKyun Na, Sangtaek Oh. Phytother Res 2019
22
25



miR-224-5p-enriched exosomes promote tumorigenesis by directly targeting androgen receptor in non-small cell lung cancer.
Jinbao Zhou, Hongshu Wang, Qiangling Sun, Xiaomin Liu, Zong Wu, Xianyi Wang, Wentao Fang, Zhongliang Ma. Mol Ther Nucleic Acids 2021
16
25


Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients.
Andriani Charpidou, Ioannis Gkiozos, Marios Konstantinou, Anastasia Eleftheraki, Panagiotis Demertzis, Kevin Harrington, Aris Polyzos, Kostas N Syrigos. Cancer Lett 2011
10
25

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
Fei Song, Bo Hu, Jian-Wen Cheng, Yun-Fan Sun, Kai-Qian Zhou, Peng-Xiang Wang, Wei Guo, Jian Zhou, Jia Fan, Zhong Chen,[...]. Cell Death Dis 2020
32
25

Control of proteinase expression by phorbol-ester- and Fos-dependent pathways in human non-small-cell lung-cancer cells.
M Schuermann, R Jäger, U Salge, G Risse-Hackl, K Havemann, H H Heidtmann. Int J Cancer 1997
4
25


Lower Sympathetic Nervous System Density and β-adrenoreceptor Expression Are Involved in Gastric Cancer Progression.
Go Eun Bae, Hyun-Soo Kim, Kyu Yeoun Won, Gou Young Kim, Ji-Youn Sung, Sung-Jig Lim. Anticancer Res 2019
8
25


Ubiquitin ligases in oncogenic transformation and cancer therapy.
Daniela Senft, Jianfei Qi, Ze'ev A Ronai. Nat Rev Cancer 2018
212
25


Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
Guofang Guan, Ranwei Li, Wenfang Tang, Tiecheng Liu, Zhenzhong Su, Yan Wang, Jingjin Tan, Shan Jiang, Ke Wang. Tumour Biol 2017
6
25

Multifunctional silica-coated mixed polymeric micelles for integrin-targeted therapy of pediatric patient-derived glioblastoma.
Prakram Singh Chauhan, Murali Kumarasamy, Angel M Carcaboso, Alejandro Sosnik, Dganit Danino. Mater Sci Eng C Mater Biol Appl 2021
2
50

Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
Bin Liu, Julio Ricarte Filho, Apurva Mallisetty, Cassandra Villani, Anastasia Kottorou, Kristen Rodgers, Chen Chen, Tomoaki Ito, Kyla Holmes, Nicole Gastala,[...]. Clin Cancer Res 2020
29
25

Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.
Dörte Nitschkowski, Sebastian Marwitz, Sousana A Kotanidou, Martin Reck, Christian Kugler, Klaus F Rabe, Ole Ammerpohl, Torsten Goldmann. Clin Epigenetics 2019
10
25

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination.
Ce Li, Lutao Du, Yidan Ren, Xiaoyan Liu, Qinlian Jiao, Donghai Cui, Mingxin Wen, Chuanxin Wang, Guangwei Wei, Yunshan Wang,[...]. J Exp Clin Cancer Res 2019
40
25

Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy.
Vilde D Haakensen, Anand Khadse, Vandana Sandhu, Ann Rita Halvorsen, Steinar K Solberg, Lars H Jørgensen, Odd Terje Brustugun, Elin H Kure, Åslaug Helland. Int J Cancer 2020
4
25

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Xin Dong, Dong Lin, Chris Low, Emily A Vucic, John C English, John Yee, Nevin Murray, Wan L Lam, Victor Ling, Stephen Lam,[...]. J Thorac Oncol 2013
32
25

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Yajuan Cao, Weikang Zhu, Wanqing Chen, Jianchun Wu, Guozhen Hou, Yan Li. Dis Markers 2019
28
25

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.
Fatéméh Dubois, Maureen Keller, Julien Hoflack, Elodie Maille, Martine Antoine, Virginie Westeel, Emmanuel Bergot, Elisabeth Quoix, Armelle Lavolé, Laurence Bigay-Game,[...]. Cancers (Basel) 2019
3
33

Recent Advances on Small-Molecule Survivin Inhibitors
Min Xiao, Wei Li. Curr Med Chem 2015
23
25

XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Jiao Ji, Yan Yu, Zhi-Ling Li, Ming-Yuan Chen, Rong Deng, Xiang Huang, Guang-Feng Wang, Meng-Xia Zhang, Qi Yang, Senthilkumar Ravichandran,[...]. Theranostics 2018
30
25

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway.
Sushil Kumar, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, John W Tobias, Christian W Siebel, Mario Andres Blanco, Andres J Klein-Szanto, Christopher Lengner,[...]. Nat Commun 2021
18
25

LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Chengcheng Yang, Huangzhen Wang, Boxiang Zhang, Yimeng Chen, Yamin Zhang, Xin Sun, Guodong Xiao, Kejun Nan, Hong Ren, Sida Qin. J Exp Clin Cancer Res 2016
37
25

Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
Yoon Hyeon Kim, Eun Ah Shin, Ji Hoon Jung, Ji Eon Park, Jinsuk Koo, Ja Il Koo, Bum Sang Shim, Sung-Hoon Kim. Eur J Pharmacol 2019
10
25

NF-kappaB: a signal for cancer.
Derek A Mann, Fiona Oakley. J Hepatol 2005
15
25

NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies.
Peng Liu, Ziwen Lu, Lanlan Liu, Ruyan Li, Zhiquan Liang, Mingxiang Shen, Han Xu, Dewan Ren, Mengchen Ji, Sirui Yuan,[...]. Phytomedicine 2019
41
25

Survivin expression and impact on head and neck cancer outcomes.
Saad A Khan, Michael Burke, Fang Zhu, Dong-Hua Yang, Cara Dubyk, Ranee Mehra, Miriam J Lango, John A Ridge, David J Sher, Barbara Burtness. Oral Oncol 2021
5
25

Artemether Attenuates the Progression of Non-small Cell Lung Cancer by Inducing Apoptosis, Cell Cycle Arrest and Promoting Cellular Senescence.
Jian Chen, Xiaofei Huang, Cheng Tao, Ting Xiao, Xinping Li, Qiang Zeng, Min Ma, Zhengzhi Wu. Biol Pharm Bull 2019
18
25

Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
Yoon Kyung Jeon, Chung Kwon Kim, Jaemoon Koh, Doo Hyun Chung, Geun-Hyoung Ha. Oncotarget 2016
22
25

Recent advances in nanomedicine and survivin targeting in brain cancers.
Jake Mazur, Kislay Roy, Jagat R Kanwar. Nanomedicine (Lond) 2018
17
25

Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4.
Deok Soo Ahn, Hyo Jung Lee, Jisung Hwang, Hyukgyu Han, Bonglee Kim, BumSang Shim, Sung-Hoon Kim. Int J Mol Sci 2018
13
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.